http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2775902-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d7e470e09803bd6bf24b2fd176109dd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2278 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate | 1998-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56d2dac8572b1b749deff312f34b7d68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18d25d37b3bef48a663bcb31f8663b29 |
| publicationDate | 1999-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2775902-A1 |
| titleOfInvention | USE OF VIP ANALOGS IN THE PREVENTION AND TREATMENT OF BRAIN INJURIES IN THE HUMAN NEWBORN |
| abstract | New use of VIP analogues in the prevention and/or treatment of cerebral lesions in the human fetus, newborn or young infant. Said VIP analog is selected from the group consisting of cyclic VIP analogs and non-cyclic VIP derivatives of 28 amino acids comprising in the N-terminal position an N-acetyl group, then Glu in position 8 (Glu8), Lys in position 12 (Lys12), norleucine at position 17 (Nle17), Ala at position 19 (Ala19), X1 at position 21, X2 at position 25, Leu at position 26 (Leu26), Lys at positions 27 and 28 (Lys27 and Lys28) , Gly at position 29 and 30 (Gly29 and Gly30) and Thr at position 31 (Thr31), X1 representing Lys (Lys21) or Nle (Nle21) and X2 representing Asp (Asp25) or Asn (Asn25). |
| priorityDate | 1998-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.